Jones Financial Companies
ABEO icon

Jones Financial Companies’s Abeona Therapeutics ABEO Stock Holding History

Jones Financial Companies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61K Hold
1,000
– – ﹤0.01% 4045
2026
Q1 		$4.29K Hold
1,000
– – ﹤0.01% 3898
2025
Q4 		$5.27K Hold
1,000
– – ﹤0.01% 3474
2025
Q3 		$5.44K Hold
1,000
– – ﹤0.01% 3333
2025
Q2 		$5.75K Hold
1,000
– – ﹤0.01% 3093
2025
Q1 		$4.97K Buy
+1,000
New +$5.44K ﹤0.01% 2962

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jones Financial Companies's ABEO Position: Q2 2026 in Review

Jones Financial Companies held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 1,000 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

Jones Financial Companies first reported a position in ABEO in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.75K in Q2 2025. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Jones Financial Companies held 1,000 shares of Abeona Therapeutics worth $5.61K as of Q2 2026.
  • Jones Financial Companies left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4045 holding.
  • Jones Financial Companies first reported a position in Abeona Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Abeona Therapeutics position peaked at $5.75K in Q2 2025.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.